Psychopharmacological treatment of bipolar disorder in Latin American

[1]  M. Alda,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. , 2013, Bipolar disorders.

[2]  Megan M. Filkowski,et al.  Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. , 2010, The Journal of clinical psychiatry.

[3]  G. MacQueen,et al.  Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review , 2010, British Journal of Psychiatry.

[4]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[5]  J. Haro,et al.  Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). , 2009, Journal of affective disorders.

[6]  Arun Ravindran,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. , 2013, Bipolar disorders.

[7]  T. Suppes,et al.  Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. , 2009, The American journal of psychiatry.

[8]  A. Wingo,et al.  Long‐term antidepressant treatment in bipolar disorder: meta‐analyses of benefits and risks , 2008, Acta psychiatrica Scandinavica.

[9]  C. Depp,et al.  Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004. , 2008, Psychiatric services.

[10]  David J Miklowitz,et al.  Effectiveness of adjunctive antidepressant treatment for bipolar depression. , 2007, The New England journal of medicine.

[11]  Hans-Jürgen Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[12]  F. Goodwin,et al.  Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. , 2006, Bipolar disorders.

[13]  A. Nierenberg,et al.  Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants. , 2006, Psychiatric services.

[14]  J. Geddes,et al.  Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. , 2005, The American journal of psychiatry.

[15]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[16]  John R Geddes,et al.  Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. , 2004, The American journal of psychiatry.

[17]  L. Yatham.  Newer anticonvulsants in the treatment of bipolar disorder. , 2004, The Journal of clinical psychiatry.

[18]  H. Akiskal,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment , 2004, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[19]  F. Goodwin,et al.  Antidepressants in bipolar disorder: the case for caution. , 2003, Bipolar disorders.

[20]  T. Suppes,et al.  Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. , 2003, The American journal of psychiatry.

[21]  S. Frangou,et al.  The Maudsley bipolar disorder project Clinical characteristics of bipolar disorder I in a Catchment area treatment sample , 2003, European Psychiatry.

[22]  S. Frangou,et al.  The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder. , 2002, Bipolar disorders.

[23]  M. Tohen,et al.  Pharmacotherapy patterns in the treatment of bipolar disorder. , 2002, Bipolar disorders.

[24]  M. Olfson,et al.  Trends in the treatment of bipolar disorder by outpatient psychiatrists. , 2002, The American journal of psychiatry.

[25]  John A. Rice,et al.  The long-term natural history of the weekly symptomatic status of bipolar I disorder. , 2002, Archives of general psychiatry.

[26]  A J Rush,et al.  The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. , 2001, Journal of affective disorders.

[27]  M. Tohen,et al.  Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. , 2001, Bipolar disorders.

[28]  R. Baldessarini,et al.  Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. , 2001, The Journal of clinical psychiatry.

[29]  J. Brar,et al.  Illness characteristics and their association with prescription patterns for bipolar I disorder. , 2001, Bipolar disorders.

[30]  D. Kupfer,et al.  Psychotropic drug prescription patterns among patients with bipolar I disorder. , 2000, Bipolar disorders.

[31]  M. Tohen,et al.  Prescribing trends of antidepressants in bipolar depression. , 1995, The Journal of clinical psychiatry.

[32]  A. Brnabic,et al.  Pharmacological treatment outcomes in Latin American patients with bipolar I disorder , 2009 .

[33]  K. Krishnan,et al.  Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder. , 2008, Psychopharmacology bulletin.

[34]  R. Baldessarini,et al.  Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. , 2007, Psychiatric services.

[35]  A. Kilbourne,et al.  Patterns of psychotropic medication use by race among veterans with bipolar disorder. , 2006, Psychiatric services.

[36]  S. Strejilevich,et al.  [Argentine consensus on the treatment of bipolar disorders]. , 2005, Vertex.

[37]  R. Baldessarini,et al.  Antidepressant treatment in bipolar versus unipolar depression. , 2004, The American journal of psychiatry.

[38]  R. Baldessarini,et al.  Suicidal Behaviour in Bipolar Disorder , 2003, CNS drugs.

[39]  H. Möller,et al.  Task Force on Treatment Guidelines for Bipolar Disorders , 2002 .

[40]  J. Kane,et al.  Extending indications for long-term pharmacotherapy: opportunities and challenges. , 2002, The American journal of psychiatry.

[41]  F. Goodwin.  Manic-Depressive Illness , 1990 .